APEXECM
Live / Applied — Statement of use — registration review complete (as of 11 Sept 2026)
What this means for you
Not registered yet, but its 01 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98781297
- Mark type
- Stylized text
- Filed
- 01 Oct 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Steven Rinehart
Goods and services
- Class 005 — Pharmaceuticals: Human allograft tissue; Synthetic peptides for the treatment of tissue damage; Human allograft bone and tissue
Owner
- Kolosis Bio,, LLC, Salt Lake City, UT, US
- Kolosis Bio,, LLC, Salt Lake City, UT, US
Prosecution history
- 11 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Apr 2026 — USE AMENDMENT FILED
- 21 Apr 2026 — TEAS STATEMENT OF USE RECEIVED
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2025 — SOU EXTENSION 1 GRANTED
- 19 Nov 2025 — SOU EXTENSION 1 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Mar 2025 — ASSIGNED TO EXAMINER